INTRODUCTION: Traumatic injury may result in an exaggerated response to subsequent immune stimuli such as nosocomial infection. This "second hit" phenomenon and molecular mechanism(s) of immune priming by traumatic lung injury, specifically, pulmonary contusion, remain unknown. We used an animal model of pulmonary contusion to determine whether the injury resulted in priming of the innate immune response and to test the hypothesis that resuscitation fluids could attenuate the primed response to a second hit. METHODS: Male, 8 to 9 weeks, C57/BL6 mice with a pulmonary contusion were challenged by a second hit of intratracheal administration of the Toll-like receptor 4 agonist, lipopolysaccharide (LPS, 50 microg) 24 hours after injury (injury + LPS). Other experimental groups were injury + vehicle or LPS alone. A separate group was injured and resuscitated by 4 cc/kg of hypertonic saline (HTS) or Lactated Ringer's (LR) resuscitation before LPS challenge. Mice were killed 4 hours after LPS challenge and blood, bronchoalveolar lavage, and tissue were isolated and analyzed. Data were analyzed using one-way analysis of variance with Bonferroni multiple comparison posttest for significant differences (*p < or = 0.05). RESULTS: Injury + LPS showed immune priming observed by lung injury histology and increased bronchoalveolar lavage neutrophilia, lung myeloperoxidase and serum IL-6, CXCL1, and MIP-2 levels when compared with injury + vehicle or LPS alone. After injury, resuscitation with HTS, but not Lactated Ringer's was more effective in attenuating the primed response to a second hit. CONCLUSION: Pulmonary contusion primes innate immunity for an exaggerated response to a second hit with the Toll-like receptor 4 agonist, LPS. We observed synergistic increases in inflammatory mediator expression in the blood and a more severe lung injury in injured animals challenged with LPS. This priming effect was reduced when HTS was used to resuscitate the animal after lung contusion.
INTRODUCTION:Traumatic injury may result in an exaggerated response to subsequent immune stimuli such as nosocomial infection. This "second hit" phenomenon and molecular mechanism(s) of immune priming by traumatic lung injury, specifically, pulmonary contusion, remain unknown. We used an animal model of pulmonary contusion to determine whether the injury resulted in priming of the innate immune response and to test the hypothesis that resuscitation fluids could attenuate the primed response to a second hit. METHODS: Male, 8 to 9 weeks, C57/BL6mice with a pulmonary contusion were challenged by a second hit of intratracheal administration of the Toll-like receptor 4 agonist, lipopolysaccharide (LPS, 50 microg) 24 hours after injury (injury + LPS). Other experimental groups were injury + vehicle or LPS alone. A separate group was injured and resuscitated by 4 cc/kg of hypertonic saline (HTS) or Lactated Ringer's (LR) resuscitation before LPS challenge. Mice were killed 4 hours after LPS challenge and blood, bronchoalveolar lavage, and tissue were isolated and analyzed. Data were analyzed using one-way analysis of variance with Bonferroni multiple comparison posttest for significant differences (*p < or = 0.05). RESULTS: Injury + LPS showed immune priming observed by lung injury histology and increased bronchoalveolar lavage neutrophilia, lung myeloperoxidase and serum IL-6, CXCL1, and MIP-2 levels when compared with injury + vehicle or LPS alone. After injury, resuscitation with HTS, but not Lactated Ringer's was more effective in attenuating the primed response to a second hit. CONCLUSION: Pulmonary contusion primes innate immunity for an exaggerated response to a second hit with the Toll-like receptor 4 agonist, LPS. We observed synergistic increases in inflammatory mediator expression in the blood and a more severe lung injury in injured animals challenged with LPS. This priming effect was reduced when HTS was used to resuscitate the animal after lung contusion.
Authors: Hugh M Paterson; Thomas J Murphy; Elizabeth J Purcell; Odhran Shelley; Sara J Kriynovich; Egil Lien; John A Mannick; James A Lederer Journal: J Immunol Date: 2003-08-01 Impact factor: 5.422
Authors: K L Mattox; P A Maningas; E E Moore; J R Mateer; J A Marx; C Aprahamian; J M Burch; P E Pepe Journal: Ann Surg Date: 1991-05 Impact factor: 12.969
Authors: D James Cooper; Paul S Myles; Francis T McDermott; Lynette J Murray; John Laidlaw; Gregory Cooper; Ann B Tremayne; Stephen S Bernard; Jennie Ponsford Journal: JAMA Date: 2004-03-17 Impact factor: 56.272
Authors: Lane M Smith; Jonathan D Wells; Vidula T Vachharajani; Barbara K Yoza; Charles E McCall; J Jason Hoth Journal: J Trauma Acute Care Surg Date: 2015-05 Impact factor: 3.313
Authors: Robert Southard; Sarbani Ghosh; Julia Hilliard; Chris Davis; Cristina Mazuski; Andrew Walton; Richard Hotchkiss Journal: Shock Date: 2012-06 Impact factor: 3.454
Authors: Vladislav A Dolgachev; Bi Yu; Lei Sun; Thomas P Shanley; Krishnan Raghavendran; Mark R Hemmila Journal: Shock Date: 2014-04 Impact factor: 3.454
Authors: J Jason Hoth; Jonathan D Wells; Sarah E Jones; Barbara K Yoza; Charles E McCall Journal: J Trauma Acute Care Surg Date: 2014-03 Impact factor: 3.313
Authors: Sung Yang; David Stepien; Dennis Hanseman; Bryce Robinson; Michael D Goodman; Timothy A Pritts; Charles C Caldwell; Daniel G Remick; Alex B Lentsch Journal: Crit Care Med Date: 2014-09 Impact factor: 7.598